Posts Tagged ‘Ace’
Friday, February 25th, 2011
Nothing generates buzz during the early days of spring training like an injury to the team's newly acquired ace, but Cliff Lee said Monday that his strained side muscle is fine, and he's still on track to open the season as planned.
Tags: Ace, Buzz, Cliff Lee, Muscle Strain, Spring Training
Posted in Main Content | No Comments »
Thursday, January 6th, 2011
( Muscular Dystrophy Association ) MDA awards $1.5 million grant to continue promising research for Duchenne muscular dystrophy. DMD mainly affects young boys who can lose ability to walk and who's lives are dramatically shortened by the disease.
Tags: 5 Million, Ace, Dmd, Mda, Muscular Dystrophy Association, Promising Research, Young Boys
Posted in Main Content | No Comments »
Thursday, September 9th, 2010
CAMBRIDGE, Mass.----Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, and Shire plc , the global specialty biopharmaceutical company, today announced a joint development and commercialization agreement for ACE-031 and other novel molecules targeting the ...
Tags: Acceleron Pharma, Ace, Biopharmaceutical Company, Cambridge Mass, Cells And Tissues, Commercialization, Novel Molecules, Novel Therapeutics, Plc, Red Blood Cells, Shire, Vasculature
Posted in Main Content | No Comments »
Monday, September 6th, 2010
CHICAGO -- New York Mets ace Johan Santana will miss his next scheduled start because of a strained left pectoral muscle. His outing Tuesday at Washington had been up in the air since he left Thursday's win over Atlanta after five innings.
Tags: Ace, Chicago New York, Johan Santana, Left Pectoral Muscle, New York Mets
Posted in Main Content | No Comments »
Sunday, September 5th, 2010
CHICAGO (AP) — New York Mets ace Johan Santana will miss his next scheduled start because of a strained left pectoral muscle.
Tags: Ace, Johan Santana, Left Pectoral Muscle, New York Mets
Posted in Main Content | No Comments »